Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology

Mechanism-based therapy centred on the molecular understanding of disease-causing pathways in a given patient is still the exception rather than the rule in medicine, even in cardiology. However, recent successful drug developments centred around the second messenger cyclic guanosine-3′-5′-monophosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Petraina, Alexandra, Nogales, Cristian, Krahn, Thomas, Mucke, Hermann, Lüscher, Thomas F, Fischmeister, Rodolphe, Kass, David A, Burnett, John C, Hobbs, Adrian J, Schmidt, Harald H H W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302891/
https://www.ncbi.nlm.nih.gov/pubmed/34270705
http://dx.doi.org/10.1093/cvr/cvab240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302891/
https://www.ncbi.nlm.nih.gov/pubmed/34270705
http://dx.doi.org/10.1093/cvr/cvab240

Ejemplares similares